Gábor Katona, Bence Sipos, & Ildikó Csóka. (2022). Risk-Assessment-Based Optimization Favours the Development of Albumin Nanoparticles with Proper Characteristics Prior to Drug Loading. MDPI AG.
Chicago Style (17th ed.) CitationGábor Katona, Bence Sipos, and Ildikó Csóka. Risk-Assessment-Based Optimization Favours the Development of Albumin Nanoparticles with Proper Characteristics Prior to Drug Loading. MDPI AG, 2022.
MLA (9th ed.) CitationGábor Katona, et al. Risk-Assessment-Based Optimization Favours the Development of Albumin Nanoparticles with Proper Characteristics Prior to Drug Loading. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.